Overview
- 31 inspections across 30 sites are on record.
- 5 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-12.
At a glance
Inspections
31
Sites
30
Observations
5
Career since
Aug 2023
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| TRS Labs, Inc. | 12 May 2026 | Animal Drugs & Feeds | On file |
| Jiangsu Center for Safety Evaluation of Drugs | 3 Apr 2026 | Human Drugs | On file |
| John (NMI) Nguyen, MD | 11 Feb 2026 | Human Drugs | |
| Rachel L. Mitchell, M.D. | 18 Dec 2025 | Human Drugs | |
| D. Brandon Williams, M.D. | 19 Nov 2025 | Medical Devices & Rad Health |
Sites inspected
TRS Labs, Inc.Athens, United States1 insp.
Jiangsu Center for Safety Evaluation of DrugsNanjing, China1 insp.
John (NMI) Nguyen, MDMorgantown, United States1 insp.
Rachel L. Mitchell, M.D.Nashville, United States1 insp.
D. Brandon Williams, M.D.Nashville, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Laura L Staples5 shared
Matthew R Coleman2 shared
Mark J Seaton1 shared
Zhou Chen1 shared
Carmen Y Fisher1 shared
Brittany L Carpenter1 shared
Kellie R Riggs1 shared
Ann B Borromeo1 shared
Christopher M Jeffers1 shared
Sheri L Stephenson1 shared
Full investigator report
Get the verbatim findings behind Marshall A Naimo's 5 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site